HOME >> MEDICINE >> NEWS
Ovarian carcinoma, ethnicity, and survival

African-American women with ovarian carcinoma have a 30% greater risk of death from any cause and are more likely to die earlier when compared to Caucasian women with ovarian cancer. Findings in a recent study published in the March 15, 2002, issue of CANCER* indicate that ethnicity itself is a risk factor in ovarian cancer survival even after adjustment for prognostic factors that showed ethnic differences. Differences in prognostic factors were observed in age at diagnosis, marital status, stage of tumor, and site-specific surgical treatment.

Ovarian cancer causes more deaths per year than all other female reproductive cancers. Ethnicity, parity, oral contraception use, and breast feeding are all predictive factors for development of ovarian cancer. Factors that predict poor prognosis include higher disease stage and older age. Other studies have also shown that African-Americans with ovarian cancer have higher mortality rates than Caucasians with ovarian cancer. While ethnicity is a risk factor, little is known about the differences in prognostic factors between Caucasians and African-Americans with ovarian cancer that could effect survival. In a retrospective study of over 13,000 women with ovarian cancer, Barnholtz-Sloan et al analyzed data for differences in prognostic factors between Caucasians and African-Americans and the effect of these differences on ovarian cancer survival.

Data from 12,285 Caucasian women and 798 African-American women diagnosed with primary, malignant ovarian carcinoma was analyzed from the Surveillance, Epidemiology, and End Results (SEER) Program. SEER is a population-based national cancer surveillance database with demographic, clinical, treatment and survival information on men and women diagnosed with cancer. Factors included the database and analyzed in this study include marital status, age at diagnosis, tumor stage, tumor histology and grade, lymph node involvement, site-specific surgical treatment, and
'"/>

Contact: David Greenberg
dgreenbe@wiley.com
212-850-6484
John Wiley & Sons, Inc.
14-Mar-2002


Page: 1 2

Related medicine news :

1. Ovarian cancer does have early warning signs, Mayo Clinic and Olmsted Medical Center find
2. Ovarian cancer rates across Europe
3. Ovarian tissue storage and later transplant shows promise for women infertile from cancer therapy
4. Ovarian Hormone Could Play Key Role In Easier, Safer Childbirth
5. Age, ethnicity, income impact exercise habits of elderly
6. Hormonal treatment improves survival in high-risk prostate cancer patients
7. Lack of clinical trial participation may contribute to lower survival rates
8. Alcohol relapse adversely affects 10-year liver transplant survival
9. Donor age has no affect on long-term liver transplant survival
10. Specialist care gives better rate of survival
11. Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ovarian carcinoma ethnicity and survival

(Date:7/24/2014)... night, which shuts off nighttime production of the hormone ... widely used breast cancer drug, says a new study ... study, "Circadian and Melatonin Disruption by Exposure to Light ... Breast Cancer," published in the journal Cancer Research ... vital to the success of tamoxifen in treating breast ...
(Date:7/24/2014)... Ticket Down is a reliable source for cheap ... Sports Authority Field on July 26th. For the past four years, ... of the best club teams from around the world to North ... about weeks after its completion, fans – new and old alike ... stars in the world compete. Some of these players were already ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 Four ... this month of its $3 million renovation of the ... Lokelani presidential/residential three-bedroom suites, just in time to welcome ... , With design direction from the internationally-acclaimed BraytonHughes Design ... largest on the property and the largest in Hawaii—received ...
(Date:7/24/2014)... In a July 9th article in the ... Lotus Blossom Consulting LLC , was quoted in a ... to Cut the High Cost of Infertility . Her advice ... to maximize your chance of success from the first attempt.” ... , “I am always happy to talk with the ...
(Date:7/24/2014)... County, NJ (PRWEB) July 24, 2014 ... a leading specialist in hematology and oncology, Dr. ... Medical Group. Our system welcomes Dr. Upadhyaya to ... physicians comprise CarePoint Health Medical Group, a comprehensive ... County, representing a wide range of specialties. This ...
Breaking Medicine News(10 mins):Health News:Total darkness at night is key to success of breast cancer therapy -- Tulane study 2Health News:Manchester United vs. AS Roma Tickets Denver Sports Authority Field at Mile High: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match 2Health News:Manchester United vs. AS Roma Tickets Denver Sports Authority Field at Mile High: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match 3Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 2Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 3Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 4Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 5Health News:Mindy Berkson, Infertility Expert and Founder, Lotus Blossom Consulting LLC: Leading the Pathway to Parenthood 2Health News:Mindy Berkson, Infertility Expert and Founder, Lotus Blossom Consulting LLC: Leading the Pathway to Parenthood 3Health News:Dr. Upadhyaya Joins CarePoint Health Medical Group 2
(Date:7/24/2014)... PLAINFIELD, N.J. , July 24, 2014  PTC ... that the Company will host a webcast conference call ... provide an update on the company,s business and outlook ... before the opening of the market. ... (domestic) or (973) 935-8152 (international) five minutes prior to ...
(Date:7/24/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... today reported financial results for the first fiscal quarter ... , Revenues of $47.5 million, up 10% over ... $0.21, up 50% over last year,s comparable quarter. ... $7.2 million, up 20% over last year,s comparable quarter. ...
(Date:7/24/2014)... 2014 IGI Laboratories, Inc. (NYSE MKT: IG), ... generic pharmaceutical company, today announced it has accepted  ... Mr. Finio has accepted a senior level finance position ... his acceptance of his new position, Mr. Finio will ... for IGI Laboratories, Inc.  The effective date of his ...
Breaking Medicine Technology:Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11IGI Laboratories, Inc. Announces Change To Its Board Of Directors 2
Cached News: